今日评论（2024._老虎社区_美港股上老虎

牛唐
08-09

今日评论（2024.08.08）
1、 $Tarsus Pharmaceuticals, Inc.(TARS)$ 财报发布，是否有配置机会？
2、礼来合作伙伴 $ProQR Therapeutics N.V.(PRQR)$ 下半年有哪些看点？
3、暴跌后的 $英伟达(NVDA)$ 是否还有下行风险？
$纳指100ETF(QQQ)$ $台积电(TSM)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":336691269718040,"tweetId":"336691269718040","gmtCreate":1723208744146,"gmtModify":1723208746588,"author":{"id":3452938437060827,"idStr":"3452938437060827","authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"社区优质创作者：发表过3篇及以上精华帖，且30天内发表过至少一篇精华帖并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.23","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":6215,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>今日评论（2024.08.08）\n 1、 <a href=\"https://laohu8.com/S/TARS\">$Tarsus Pharmaceuticals, Inc.(TARS)$</a> 财报发布，是否有配置机会？\n 2、礼来合作伙伴 <a href=\"https://laohu8.com/S/PRQR\">$ProQR Therapeutics N.V.(PRQR)$</a> 下半年有哪些看点？\n 3、暴跌后的 <a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$</a> 是否还有下行风险？\n <a href=\"https://laohu8.com/S/QQQ\">$纳指100ETF(QQQ)$</a> <a href=\"https://laohu8.com/S/TSM\">$台积电(TSM)$</a></body></html>","htmlText":"<html><head></head><body>今日评论（2024.08.08）\n 1、 <a href=\"https://laohu8.com/S/TARS\">$Tarsus Pharmaceuticals, Inc.(TARS)$</a> 财报发布，是否有配置机会？\n 2、礼来合作伙伴 <a href=\"https://laohu8.com/S/PRQR\">$ProQR Therapeutics N.V.(PRQR)$</a> 下半年有哪些看点？\n 3、暴跌后的 <a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$</a> 是否还有下行风险？\n <a href=\"https://laohu8.com/S/QQQ\">$纳指100ETF(QQQ)$</a> <a href=\"https://laohu8.com/S/TSM\">$台积电(TSM)$</a></body></html>","text":"今日评论（2024.08.08） 1、 $Tarsus Pharmaceuticals, Inc.(TARS)$ 财报发布，是否有配置机会？ 2、礼来合作伙伴 $ProQR Therapeutics N.V.(PRQR)$ 下半年有哪些看点？ 3、暴跌后的 $英伟达(NVDA)$ 是否还有下行风险？ $纳指100ETF(QQQ)$ $台积电(TSM)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/336691269718040","repostId":0,"isVote":1,"tweetType":1,"viewCount":1149,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVDA","QQQ","PRQR","TARS","TSM"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":211,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}